Verified employee & interview reviews

HCG Cancer Centre Reviews

Bengaluru, Karnataka

4.3/ 5

3 reviews

Healthcare Global Enterprises Limited (HCG), operating under the brand HCG Cancer Centre, is a premier specialty healthcare provider and stands as India's largest cancer care network. Headquartered in Bengaluru, Karnataka, the company was originally incorporated in March 1998 as Curie Centre of Oncology Private Limited before transitioning to its current name. HCG pioneered a unique, networked model in oncology, offering comprehensive cancer diagnosis and treatment services, including medical oncology, surgical oncology, and radiation therapy. Beyond its core focus on oncology, HCG has diversified its healthcare offerings. It operates a chain of multi-specialty hospitals providing tertiary care and has a significant presence in reproductive medicine through its wholly-owned subsidiary, BACC Healthcare Private Limited, which runs fertility centers under the "Milann" brand. Additionally, its Triesta Sciences division offers advanced precision diagnostics and clinical laboratory services. HCG's network spans across India, encompassing over 20 comprehensive cancer centers, multi-specialty hospitals, and day-care chemotherapy centers across major metropolitan hubs as well as tier-II and tier-III cities. To address growing healthcare demands in international markets, the company has also expanded its footprint into Africa, establishing a comprehensive cancer care center in Nairobi, Kenya. The company's clinical framework relies heavily on advanced technology and a robust pool of medical talent. HCG's facilities utilize state-of-the-art equipment, including CyberKnife, TomoTherapy, robotic surgery tools, linear accelerators (LINAC), and digital PET-CT scanners, enabling precise, value-based medicine. Its multidisciplinary care model is supported by a large network of specialists, featuring more than 400 oncologists and hundreds of experienced physicians dedicated to personalized patient outcomes. Financially, Healthcare Global Enterprises Limited is publicly traded on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker HCG. The company has pursued aggressive capacity growth, consistently expanding its bed count, upgrading existing infrastructure, and executing key regional acquisitions—such as acquiring specialty hospitals and majority stakes in oncology centers across states like Gujarat, Maharashtra, West Bengal, and Andhra Pradesh. For the fiscal period ending in recent years, the company reported consolidated annual revenues exceeding INR 1,000 crore, driven by climbing patient footfalls, improved average revenue per occupied bed (ARPOB), and the stabilization of its newer healthcare facilities. Controlled by strong institutional backers and guided by executive leadership, HCG continues to emphasize integrated reporting and healthcare innovation across South Asia and Africa.